CREDIT SUISSE AG/ - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 178 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,548,081
-11.1%
75,553
-13.7%
0.00%0.0%
Q2 2023$1,740,533
+43.7%
87,596
+23.8%
0.00%
+100.0%
Q1 2023$1,211,622
-5.4%
70,731
+8.0%
0.00%0.0%
Q4 2022$1,281,346
+157.8%
65,475
+110.2%
0.00%0.0%
Q3 2022$497,000
+15.9%
31,154
-0.2%
0.00%
Q2 2022$429,000
-10.8%
31,221
+2.9%
0.00%
Q1 2022$481,000
-22.2%
30,345
+7.2%
0.00%
Q4 2021$618,000
-22.5%
28,302
+6.2%
0.00%
Q3 2021$797,000
-26.7%
26,659
+8.6%
0.00%
-100.0%
Q2 2021$1,087,000
-0.1%
24,553
+0.1%
0.00%0.0%
Q1 2021$1,088,000
-19.6%
24,523
-0.6%
0.00%0.0%
Q4 2020$1,354,000
-13.8%
24,668
-64.1%
0.00%0.0%
Q3 2020$1,570,000
+94.5%
68,646
+78.0%
0.00%0.0%
Q2 2020$807,000
-28.1%
38,557
-21.8%
0.00%0.0%
Q4 2019$1,122,000
+35.0%
49,289
-31.0%
0.00%0.0%
Q3 2019$831,000
+7.1%
71,395
+37.9%
0.00%0.0%
Q2 2019$776,000
+163.9%
51,758
+209.4%
0.00%
Q1 2019$294,000
-28.5%
16,731
-39.7%
0.00%
Q4 2018$411,000
+68.4%
27,765
+180.9%
0.00%
Q3 2018$244,000
-28.9%
9,885
-43.5%
0.00%
Q2 2018$343,00017,4900.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
M28 Capital Management LP 715,880$9,851,00011.04%
RTW INVESTMENTS, LP 15,802,802$217,447,0005.62%
Amitell Capital Pte Ltd 97,331$1,339,0003.05%
Prosight Management, LP 276,802$3,809,0003.00%
TANG CAPITAL MANAGEMENT LLC 1,265,900$17,419,0002.64%
Affinity Asset Advisors, LLC 250,466$3,446,0001.45%
COWEN AND COMPANY, LLC 1,000,000$13,760,0001.33%
Boxer Capital, LLC 1,466,051$20,173,0001.28%
Cormorant Asset Management, LP 868,550$11,951,0000.90%
MAVERICK CAPITAL LTD 2,532,366$34,845,0000.86%
View complete list of ROCKET PHARMACEUTICALS INC shareholders